Novartis to help make CureVac Covid-19 vaccine – Boston, Massachusetts

Boston, Massachusetts 2021-03-04 09:29:17 –

TMorning op to you. Currently, a gray sky is floating above the Pharmalot campus, but our spirit remains clear. why? It draws a little insight from the mayor of the morning, who says, “Every day, you need to open it like a precious gift.” To celebrate this concept, we are brewing even more inspiration and please join us. Our choice today is … mountain blueberries for those who are tracking this kind of thing. In the meantime, here are some interesting items. I hope your journey goes smoothly and stays safe today — remember, wear a mask….

Novartis (NVS) CureVac (CVAC) Is developing a partnership with the latest pharmaceutical company to accelerate the production of shots, The Wall Street Journal Note. The double-dose vaccine is in late-stage trials and results may come soon next month. Novartis will upgrade its factory in Kundl, Austria, with up to 50 million vaccinations this year and up to 200 million next year. Production will begin in the second quarter and delivery of key components is scheduled for the summer.

Sign up for STAT + to unlock this article and enjoy the first 30 days for free!

let’s start

Novartis to help make CureVac Covid-19 vaccine Source link Novartis to help make CureVac Covid-19 vaccine

Back to top button